Emerging Roles of Sodium Glucose Cotransporter 2 (SGLT-2) Inhibitors in Diabetic Cardiovascular Diseases: Focusing on Immunity, Inflammation and Metabolism
发布时间：2025-03-26
点击次数：
发表刊物：Front Pharmacol .
合写作者：Yang Xiao
第一作者：Lingxiang Xie
通讯作者：Shenghua Zhou2*, Zhiguang Zhou 1
是否译文：否
上一条： Chemokine CCL1 as a therapeutic target for pulmonary fibrosis: comments on 'The chemokine CCL1 triggers an AMFR？SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis'
下一条： rs3806265 and rs4612666 of the NLRP3 Gene Are Associated With the Titer of Glutamic Acid Decarboxylase Antibody in Type 1 Diabetes.